• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	Medicale Corp. (MCLE)
	Q1-CY2026	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014	Q1-CY2014
Balance Sheet Date			2025-Sep-30	2025-Jun-30	2025-Mar-31	2024-Dec-31	2024-Sep-30	2024-Jun-30	2024-Mar-31	2023-Dec-31											2021-Mar-31	2020-Dec-31
Fiscal Period			Q4-FY2025	Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024	Q3-FY2024	Q2-FY2024	Q1-FY2024											Q2-FY2021	Q1-FY2021
Total Revenue																					0$	0$
QoQ%																					.00%
YoY%
Cost Of Revenue																					0$	0$
Gross Profit																					0$	0$
Gross Margin
Operating Expenses			8,654$	3,575$	6,269$	14,995$	15,509$	9,288$	10,603$	19,307$	14,227$	8,537$	6,115$	8,714$							7,175$	11,514$
Operating Income			(8,654$)	(3,575$)	(6,269$)	(14,995$)	(15,509$)	(9,288$)	(10,603$)	(19,307$)	(14,227$)	(8,537$)	(6,115$)	(8,714$)							(7,175$)	(11,514$)
Operating Margin
Interest Income
Interest Expenses
Income Before Tax			(10,670$)	(5,528$)	(8,275$)	(16,680$)	(16,881$)	(10,461$)	(11,564$)	(19,307$)	(14,227$)	(8,537$)	(6,115$)	(8,714$)							(7,175$)	(11,514$)
Tax Expenses
Net Income			(10,670$)	(5,528$)	(8,275$)	(16,680$)	(16,881$)	(10,461$)	(11,564$)	(19,307$)	(14,227$)	(8,537$)	(6,115$)	(8,259$)							(7,175$)	(11,514$)
Profit Margin
TTM
Earnings to Minority
Earnings to Common Shareholders			(10,670$)	(5,528$)	(8,275$)	(16,680$)	(16,881$)	(10,461$)	(11,564$)	(19,307$)	(14,227$)	(8,537$)	(6,115$)	(8,259$)							(7,175$)	(11,514$)
QoQ%			(93.02%)	33.20%	50.39%	1.19%	(61.37%)	9.54%	40.11%	(35.71%)	(66.65%)	(39.61%)	25.96%								37.69%
YoY%			36.79%	47.16%	28.44%	13.61%	(18.66%)	(22.54%)	(89.11%)	(133.77%)
Earnings Per Share, Basic			0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$		0.00$		0.00$								0.00$
Earnings Per Share, Diluted			0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$								0.00$
Unlevered FCF Per Share, Basic			0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$		0.00$		0.00$								0.00$
Unlevered FCF Per Share, Diluted			0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$								0.00$
Average Shares, Basic			5,920,000	5,920,000	5,920,000	5,920,000	5,920,000	5,920,000	5,920,000	5,920,000		5,920,000		5,920,000								3,400,000
Average Shares, Diluted			5,920,000	5,920,000	5,920,000	5,920,000	5,920,000	5,920,000	5,920,000	5,920,000	5,920,000	5,920,000	5,920,000	5,920,000								3,400,000
EBIT			(10,670$)	(5,528$)	(8,275$)	(16,680$)	(16,881$)	(10,461$)	(11,564$)	(19,307$)	(14,227$)	(8,537$)	(6,115$)	(8,714$)							(7,175$)	(11,514$)
EBITDA			(10,670$)	(5,528$)	(8,275$)	(16,680$)	(16,881$)	(10,461$)	(11,564$)	(19,307$)	(14,227$)	(8,537$)	(6,115$)	(8,714$)							(6,575$)	(10,914$)

Copy Table ✓